All stock lists
NextCure, Inc. (NASDAQ:NXTC)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
5.38+0.40 (+8.03%)
Insider Score
––Not scored
NXTC Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
NXTC Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 283.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -283.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 2.59 M | 3.27 M | 2.96 M | 2.81 M | 3.20 M | 3.73 M |
| R&D Expense | 7.42 M | 6.83 M | 6.80 M | 6.14 M | 24.09 M | 7.90 M |
| Operating Expenses | 15.09 M | 9.82 M | 9.76 M | 8.95 M | 27.29 M | 11.62 M |
| Operating Income | -15.09 M | -10.11 M | -9.76 M | -8.95 M | -27.29 M | -11.62 M |
| Pretax Income | -14.89 M | -9.80 M | -9.44 M | -8.62 M | -26.81 M | -10.98 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -14.89 M | -9.80 M | -9.44 M | -8.62 M | -26.81 M | -10.98 M |
| EPS (Basic) | -2.80 | -1.87 | -2.69 | -3.22 | -11.29 | -4.70 |
| EPS (Diluted) | -2.80 | -1.87 | -2.69 | -3.22 | -11.29 | -4.70 |
| Shares Outstanding | 5.31 M | 5.24 M | 3.51 M | 2.68 M | 2.37 M | 2.33 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.